Use of twice daily darunavir as a substitution for dual boosted PIs in virologically suppressed patients: primary endpoint results of a pilot randomized clinical trial
Dr. Calvin Cohen
United States of America
16 slide(s) – 00:11:48 – English – 2009-11-12
The outcome of using darunavir in lieu of a suppressive double boosted PI regimen in HIV patients.